Story perspectives

Medvi Projects $1.8 Billion Revenue Amid Regulatory Scrutiny

4/7/2026

Summary

Story summary

Medvi, an AI-powered telehealth startup founded by Matthew Gallagher, reported $401 million in revenue last year.
It projects $1.8 billion for 2026.
The company operates with two employees and relies on affiliate marketing, about 30% of its advertising, while campaigns fell from 5,000 to 2,800.
The Food and Drug Administration (FDA) warned about false drug-approval claims.
The National Consumers League called for an FTC investigation amid lawsuits and regulatory challenges.

History

Historical Context

The Federal Food, Drug, and Cosmetic Act, enacted in 1938, established the FDA's authority to regulate drug safety following the sulfanilamide tragedy that killed over 100 people. This marked a significant shift towards federal oversight in response to public demand for consumer protection. Today, as telehealth revenues soar, the FDA continues to face challenges in regulating emerging markets and ensuring truthful claims.

1 of 2

Story summary

Medvi, an AI-powered telehealth startup founded by Matthew Gallagher, reported $401 million in revenue last year.
It projects $1.8 billion for 2026.
The company operates with two employees and relies on affiliate marketing, about 30% of its advertising, while campaigns fell from 5,000 to 2,800.
The Food and Drug Administration (FDA) warned about false drug-approval claims.
The National Consumers League called for an FTC investigation amid lawsuits and regulatory challenges.

1 / 2